Health Sciences Acquisiti... (HSAQ)
13.31
2.59 (24.16%)
At close: Jan 26, 2023, 8:59 PM
Company Description
Health Sciences Acquisitions Corporation 2 does not have significant operations.
It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe.
Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.
Health Sciences Acquisitions Corporation 2
| Country | United States |
| IPO Date | Aug 4, 2020 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Dr. Roderick Tze Ian Wong M.D. |
Contact Details
Address: 40 10th Avenue New York, New York United States | |
| Website | n/a |
Stock Details
| Ticker Symbol | HSAQ |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001814114 |
| CUSIP Number | G4411D109 |
| ISIN Number | KYG4411D1097 |
| Employer ID | 00-0000000 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Roderick Tze Ian Wong M.D. | Pres, Chief Executive Officer & Chairman |
| Dr. Naveen Yalamanchi M.D. | Executive Vice President, Chief Financial Officer & Director |
| Alice Lee J.D. | Vice President of Operations, Sec. & Treasurer |
| Stephanie A. Sirota | Vice President of Corporation Strategy & Corp. Communications |
| Stephanie Anne Sirota | Vice President of Corporation Strategy & Corp. Communications |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 04, 2025 | 4 | Filing |
| Apr 04, 2025 | 4 | Filing |
| Apr 04, 2025 | 4 | Filing |
| Apr 04, 2025 | 4 | Filing |
| Mar 31, 2025 | 10-K | Annual Report |
| Mar 28, 2025 | 4 | Filing |
| Mar 07, 2025 | 4 | Filing |
| Mar 03, 2025 | 8-K | Current Report |
| Feb 25, 2025 | 8-K | Current Report |
| Feb 19, 2025 | S-8 | Filing |